Skip to main content
. 2017 Apr 19;7(6):e00706. doi: 10.1002/brb3.706

Table 2.

Descriptive characteristics of the studies no included in the meta‐analysis

Reference Location Diagnosis Sample Units Cases Controls
n Subgroups mean SD n Subgroups Mean SD
Karege et al. (2005) Switzerland MDD, BD Hippocampus ng/g 22 Drug‐free MDD 17.7 2.9 8 Drug‐free 24.5 3.6
Drug‐free others 16.8 3.1
Drug‐treated MDD 23.3 2.2
Banerjee et al. (2013) India MDD, BD, AD, SCZ, FD, MD Hippocampus pg/ml 21 19.5 19 44
Dwivedi et al. (2003) EE.UU. MDD, AD, BD, SCZ Hippocampus Optical density 27 Suicide/MDD 1.04 0.20 21 1.71 0.44
Suicide/OPD 1.03 0.22
Hayley et al. (2015) Hungary MDD Hippocampus Optical density 9 Females‐Hippocampus 0.65 10 Females‐Hippocampus 0.55
10 Males‐Hippocampus 0.40 9 Males‐Hippocampus 0.75
Mansur et al. (20160 Brazil BD Plasma pg/ml 57 26
Grah et al. (2014) Croatia AD, MDD Serum ng/ml 96 (26) RDD 11.8 106 (60) C 13.40
(33) PD 10.7 (25) RDD 12.80
(37) AD 12.6 (26) PD 15.70
(25) AD 15.40
Martinez et al. (2012) EE.UU. MDD CFS pg/ml 18 25
Hayley et al. (2015) Hungary MDD PFC, hippocampus Optical density 9 Females 10 Females
PFC 0.75 PFC 1.40
Hippocampus 0.65 Hippocampus 0.55
10 Males 9 Males
PFC 0.50 PFC 0.40
Hippocampus 0.40 Hippocampus 0.75

MDD, major depression disorder; BD, bipolar disorder; AD, adjustment disorder; SZC, schizophrenia; FD, familiar disharmony; MD, marital disharmony; OPD, other psychiatric disorder; RDD, recurrent depressive disorder; MAD, mood and anxiety disorder; PD, psychiatric disorder; PPAD, postpartum affective disorder; PFC, prefrontal cortex; C, control.